CONCLUSION Great changes in Sickle Cell awareness was created in three northern regions of Ghana through this Advocacy Project.
With the availability of funds and similar efforts in other regions and adoption of recommendations, there is genuine prospect of greater countrywide change on the horizon.
The Counseling Units started running before official opening of clinics which was done at the end of the project.
All official opening ceremonies were covered by press. Advocacy groups made up of patients, parents and people with interest in SCD were established in all three northern regions.
The multicenter trials of hydroxyurea in the 1980s and 90s as preventive therapy reduced the need for blood transfusions, pain events and hospitalizations. This was approved for medical use by the FDA in 1998.This was solved by the use of vehicles from the Regional Hospital, Regional Health Directorate and Ministry of Education in regions. Another challenge that came up was the lack of staff for the project, since some of the trained personnel for the project had to discontinue work in the north.This was also solved by using volunteers and coordinators from the Regional Hospitals and Regional Health Directorate who were given some form of training in each region before work started.Faith groups, Social groups, Youth Clubs and Fun Associations in the Tamale, Bolgatanga and Wa Municipalities, were given the advocacy message.A room was rehabilitated for the Tamale Sickle Cell Clinic.
By the early 1990s, the Cooperative Study of Sickle Cell Disease estimated a median life expectancy of those with sickle cell anemia, the most severe form of the disease, of 42 years of age for males and 48 years of age for females. https://gov/fdavoice/index.php/2017/09/making-advances-against-sickle-cell-disease/# L-glutamine oral powder https://gov/Drugs/Information On Drugs/Approved Drugs/ucm566097N Engl J Med 2017; 38-855 March 2, 2017